Intravenously administered pamidronate for treating refractory Paget's disease of bone. de la Rosa RE, Tucci JR. Endocr Pract. 1997 Jul-Aug;3(4):214-8. doi: 10.4158/EP.3.4.214. PMID: 15251792
Re-treatment of relapsed Paget's disease of bone with zoledronic acid: results from an open-label study. Reid IR, Brown JP, Levitt N, Román Ivorra JA, Bachiller-Corral J, Ross IL, Su G, Antunez-Flores O, Aftring RP. Bonekey Rep. 2013 Nov 06;2:442. doi: 10.1038/bonekey.2013.176. eCollection 2013. PMID: 24422139
Paget's Disease of Bone in Tunisia: A Study of 69 Patients. Maatallah K, Rahmouni S, Miladi S, Rouached L, Ferjeni H, Fazaa A, Laatar A, Kaffel D, Hamdi W. Indian J Endocrinol Metab. 2020 Sep-Oct;24(5):422-427. doi: 10.4103/ijem.IJEM_239_20. Epub 2020 Nov 09. PMID: 33489848
Current perspectives on bisphosphonate treatment in Paget's disease of bone. Wat WZ. Ther Clin Risk Manag. 2014 Nov 20;10:977-83. doi: 10.2147/TCRM.S58367. eCollection 2014. PMID: 25429226